A phase I pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly.

Source:http://linkedlifedata.com/resource/pubmed/id/12702532

Download in:

View as

Triples

General Info

PMID
12702532